ADMA Biologics Inc vs Google Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Google Inc trades at $344.95 (market cap $4.20T). The key difference: Google Inc is far larger — about 1891.9× ADMA Biologics Inc's market cap, and Google Inc pays a 0.26% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | GOOG | |
|---|---|---|
Market Cap | $2.22B | $4.20T |
Sector | Health | Technology |
52-Week High | $20.38 | $399.06 |
52-Week Low | $7.60 | $200.19 |
Enterprise Value | $2.29B | $4.09T |
Volume | — | 1,511,127 |
Dividend Yield | — | 0.26% |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.
Read more on GOOG →